 |
|
Translational
Genomics.
The
Genomics program at
Saficor involves
several components:
(1) Identifying
genetic variants in
the human population.
(2) Determining the
association of the
above genetic variants
with disease. (3)
Establishing the
association of genetic
variants with patient
responses to drugs
particularly
chemotherapeutic
agents. (4) Developing
proprietary therapies
that will enhance a
patient's response to
drugs.
|
Anti-cancer Drug
Discovery.
Using proprietary
algorithms our
scientists have
identified hundreds
of active
anti-cancer
compounds with low
or no toxicity.
These compounds have
been screened
against cells, tumor
spheroids and animal
tumors. Some have
exhibited phenomenal
efficacy in human
studies. To acquire
more information on
this research visit
www.safinur.com. |
